|
1
|
Mazzeffi MA, Patel PA, Bolliger D, Erdoes G, Tanaka K. The Year in Coagulation: Selected Highlights From 2019. J Cardiothorac Vasc Anesth 2020; 34:1745-1754. [DOI: 10.1053/j.jvca.2020.01.045] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/19/2020] [Accepted: 01/27/2020] [Indexed: 12/26/2022]
|
|
2
|
Williams B, Henderson RA, Reformato VS, Pham T, Taylor BS, Tanaka KA. Hemostasis Management of Patients Undergoing Emergency Cardiac Surgery After Ticagrelor Loading. J Cardiothorac Vasc Anesth 2020; 34:168-174. [DOI: 10.1053/j.jvca.2019.06.028] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/06/2019] [Revised: 06/18/2019] [Accepted: 06/20/2019] [Indexed: 02/07/2023]
|
|
3
|
Azran M, Tanaka KA. Interaction Between Ticagrelor and CYP3A4 Inhibitor: Importance of P2Y12 Function Testing to Assess Platelet Recovery Before Surgery. J Cardiothorac Vasc Anesth 2019; 33:3221-3222. [DOI: 10.1053/j.jvca.2019.05.004] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/03/2019] [Accepted: 05/04/2019] [Indexed: 11/11/2022]
|
|
4
|
Godier A, Dupont M, Desilles JP, Le Guerinel C, Taylor G, Perrin M, Martin AC, Gaussem P. Successful Use of Recombinant Activated Factor VII to Reverse Ticagrelor-Induced Bleeding Risk: A Case Report. TH OPEN 2018; 2:e346-e349. [PMID: 31249959 PMCID: PMC6524896 DOI: 10.1055/s-0038-1672211] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2018] [Accepted: 08/20/2018] [Indexed: 12/28/2022] Open
Abstract
Management of ticagrelor-associated bleeding is challenging, especially in neurosurgery. Platelet transfusion is inefficient and no antidote is currently available. We report here the first case of recombinant activated factor VII (rFVIIa) use to bypass ticagrelor-induced platelet inhibition. A woman treated with ticagrelor and requiring emergent neurosurgery for an intracranial hematoma received preoperative high-dose platelet transfusion and 60 μg/kg rFVIIa. Laboratory monitoring demonstrated that platelet transfusion failed to reverse ticagrelor-induced platelet inhibition while rFVIIa improved hemostasis by shortening the thromboelastometric clotting time. Neurosurgery occurred without any bleeding event but the patient presented with a postoperative pulmonary embolism. In conclusion, rFVIIa may decrease ticagrelor-induced bleeding risk but careful assessment of the benefit-risk balance is warranted before using rFVIIa to reverse ticagrelor effects.
Collapse
Affiliation(s)
- Anne Godier
- Service d'Anesthésie-Réanimation, Fondation Adolphe de Rothschild, Paris, France.,Sorbonne Paris Cité, Faculté de Pharmacie, Université Paris Descartes, Paris, France.,INSERM UMR-S1140, Paris, France
| | - Mélanie Dupont
- Service d'Anesthésie-Réanimation, Fondation Adolphe de Rothschild, Paris, France
| | - Jean-Philippe Desilles
- Département de Neuroradiologie Interventionnelle, Fondation Adolphe de Rothschild, Paris, France.,Sorbonne Paris Cité, Laboratory of Vascular Translational Science, Université Paris Diderot, Paris, France.,INSERM UMR 1148, Paris, France
| | | | - Guillaume Taylor
- Service d'Anesthésie-Réanimation, Fondation Adolphe de Rothschild, Paris, France
| | - Mathilde Perrin
- Service d'Anesthésie-Réanimation, Fondation Adolphe de Rothschild, Paris, France
| | - Anne-Céline Martin
- Sorbonne Paris Cité, Faculté de Pharmacie, Université Paris Descartes, Paris, France.,INSERM UMR-S1140, Paris, France.,Service de Cardiologie, Service de Santé des Armées, Hôpital d'Instruction des Armées Percy, Clamart, France
| | - Pascale Gaussem
- Sorbonne Paris Cité, Faculté de Pharmacie, Université Paris Descartes, Paris, France.,INSERM UMR-S1140, Paris, France.,Service d'hématologie Biologique, AP-HP, Hôpital Européen Georges Pompidou, Paris, France
| |
Collapse
|
|
5
|
Essandoh M, Andritsos MJ, Dimitrova G, George B. Is Long-Acting P2Y 12 Receptor Antagonist Therapy Ideal in Patients With Recently Implanted Drug-Eluting Stents in Need of Mechanical Circulatory Support? J Cardiothorac Vasc Anesth 2018; 32:e44-e45. [DOI: 10.1053/j.jvca.2017.07.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/15/2017] [Indexed: 11/11/2022]
|